Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Current Topics in Microbiology and Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/82_2010_119PMID 21203884
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Memories that last forever: strategies for optimizing vaccine T-cell memory.

  2010cited by this paper
• Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.

  2010cited by this paper
• New paradigms for generating effective CD8+ T cell responses against HIV-1/AIDS.

  2010cited by this paper
• Lessons learned from natural infection: focusing on the design of protective T cell vaccines for HIV/AIDS.

  2010cited by this paper
• Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques

  2010cited by this paper
• Response to Comment on “Trafficking of Antigen-Specific CD8+ T Lymphocytes to Mucosal Surfaces following Intramuscular Vaccination”

  2009cited by this paper
• What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens?

  2009cited by this paper
• Strategies for optimizing targeting and delivery of mucosal HIV vaccines

  2009cited by this paper
• Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines.

  2009cited by this paper
• Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination

  2009cited by this paper
• Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines

  2008cited by this paper
• Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization.

  2008cited by this paper
• Trafficking of Antigen-Specific CD8+ T Lymphocytes to Mucosal Surfaces following Intramuscular Vaccination1

  2008cited by this paper
• Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.

  2008cited by this paper
• Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA.

  2008cited by this paper
• The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine

  2008cited by this paper
• Novel Vaccination Protocol with Two Live Mucosal Vectors Elicits Strong Cell-Mediated Immunity in the Vagina and Protects against Vaginal Virus Challenge1

  2008cited by this paper
• Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5

  2008cited by this paper
• Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope

  2008cited by this paper
• Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin.

  2008cited by this paper
• Circumvention of regulatory CD4+ T cell activity during cross‐priming strongly enhances T cell‐mediated immunity

  2008cited by this paper
• A Novel Functional CTL Avidity/Activity Compartmentalization to the Site of Mucosal Immunization Contributes to Protection of Macaques against Simian/Human Immunodeficiency Viral Depletion of Mucosal CD4+ T Cells

  2007cited by this paper
• Current concepts of HIV transmission

  2007cited by this paper
• Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17–producing T cell responses

  2007cited by this paper
• Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIV(mac251).

  2007cited by this paper
• Epitope-Dependent Avidity Thresholds for Cytotoxic T-Lymphocyte Clearance of Virus-Infected Cells

  2007cited by this paper
• Avidity of CD8 T cells sharpens immunodominance.

  2007cited by this paper
• Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing.

  2007cited by this paper
• Mucosal HIV-1 Pox Virus Prime-Boost Immunization Induces High-Avidity CD8+ T Cells with Regime-Dependent Cytokine/Granzyme B Profiles1

  2007cited by this paper
• Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules.

  2007cited by this paper
• Role of alpha3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs.

  2007cited by this paper
• Mucosal priming with PEI/DNA complex and systemic boosting with recombinant TianTan vaccinia stimulate vigorous mucosal and systemic immune responses.

  2007cited by this paper
• Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut.

  2007cited by this paper
• Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa.

  2006cited by this paper
• Mucosal vaccines: the promise and the challenge

  2006cited by this paper
• Prime-boost strategies in DNA vaccines.

  2006cited by this paper
• HIV vaccines.

  2006cited by this paper
• Preservation of Functional Virus-Specific Memory CD8+ T Lymphocytes in Vaccinated, Simian Human Immunodeficiency Virus-Infected Rhesus Monkeys1

  2006cited by this paper
• Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination.

  2006cited by this paper
• Systemic Immunization with an ALVAC-HIV-1/Protein Boost Vaccine Strategy Protects Rhesus Macaques from CD4+ T-Cell Loss and Reduces both Systemic and Mucosal Simian-Human Immunodeficiency Virus SHIVKU2 RNA Levels

  2006cited by this paper
• Enhancement of CD8+ T Cell Immunity in the Lung by CpG Oligodeoxynucleotides Increases Protective Efficacy of a Modified Vaccinia Ankara Vaccine against Lethal Poxvirus Infection Even in a CD4-Deficient Host

  2006cited by this paper
• Mucosal transmission of HIV-1: first stop dendritic cells.

  2006cited by this paper
• Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1.

  2006cited by this paper
• A DNA prime-oral Listeria boost vaccine in rhesus macaques induces a SIV-specific CD8 T cell mucosal response characterized by high levels of alpha4beta7 integrin and an effector memory phenotype.

  2006cited by this paper
• Enhanced Immunity and Protective Efficacy against SIVmac251 Intrarectal Challenge Following Ad-SIV Priming by Multiple Mucosal Routes and gp120 Boosting in MPL-SE

  2005cited by this paper
• Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells

  2005cited by this paper
• Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines

  2005cited by this paper
• CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract

  2004cited by this paper
• Progress on new vaccine strategies against chronic viral infections.

  2004cited by this paper
• Mucosal AIDS vaccines: current status and future directions

  2004cited by this paper
• Immunogenicity of Attenuated Vesicular Stomatitis Virus Vectors Expressing HIV Type 1 Env and SIV Gag Proteins: Comparison of Intranasal and Intramuscular Vaccination Routes

  2004cited by this paper
• Induction of HIV Immunity in the Genital Tract After Intranasal Delivery of a MVA Vector: Enhanced Immunogenicity After DNA Prime-Modified Vaccinia Virus Ankara Boost Immunization Schedule 1

  2004cited by this paper
• Influence of Coinfecting Pathogens on HIV Expression: Evidence for a Role of Toll-Like Receptors1

  2004cited by this paper
• Gender Differences in Human Immunodeficiency Virus Type 1-Specific CD8 Responses in the Reproductive Tract and Colon following Nasal Peptide Priming and Modified Vaccinia Virus Ankara Boosting

  2004cited by this paper
• Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells.

  2004cited by this paper
• Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines.

  2004cited by this paper
• Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract

  2004cited by this paper
• Cytokine, chemokine, and costimulatory molecule modulation to enhance efficacy of HIV vaccines.

  2003cited by this paper
• CD4+CD25+ T Cells Regulate Virus-specific Primary and Memory CD8+ T Cell Responses

  2003cited by this paper
• Mucosal Priming of Simian Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Responses in Rhesus Macaques by the Salmonella Type III Secretion Antigen Delivery System

  2003cited by this paper
• Prime-Boost Immunization Schedules Based on Influenza Virus and Vaccinia Virus Vectors Potentiate Cellular Immune Responses against Human Immunodeficiency Virus Env Protein Systemically and in the Genitorectal Draining Lymph Nodes

  2003cited by this paper
• The role of mucosal immunity in prevention of HIV transmission.

  2003cited by this paper
• Selective Induction of High Avidity CTL by Altering the Balance of Signals from APC

  2003cited by this paper
• Studies on the Generation and Maintenance of Mucosal Cytotoxic T Lymphocytes against Human Immunodeficiency Virus Type 1 Gag in Mice

  2003cited by this paper
• Molecular mechanisms and biological significance of CTL avidity.

  2003cited by this paper
• Multispecific Vaccine-Induced Mucosal Cytotoxic TLymphocytes Reduce Acute-Phase Viral Replication but Fail inLong-Term Control of Simian Immunodeficiency VirusSIVmac239

  2003cited by this paper
• Vaginal CD4+ T cells express high levels of CCR5 and are rapidly depleted in simian immunodeficiency virus infection.

  2003cited by this paper
• Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara.

  2003cited by this paper
• Containment of Simian Immunodeficiency Virus Infection in Vaccinated Macaques: Correlation with the Magnitude of Virus-Specific Pre- and Postchallenge CD4+ and CD8+ T Cell Responses1

  2002cited by this paper
• Both Mucosal and Systemic Routes of Immunization with the Live, Attenuated NYVAC/Simian Immunodeficiency Virus SIVgpe Recombinant Vaccine Result in Gag-Specific CD8+ T-Cell Responses in Mucosal Tissues of Macaques

  2002cited by this paper
• Vaccine Protection Against Functional CTL Abnormalities in Simian Human Immunodeficiency Virus-Infected Rhesus Monkeys1

  2002cited by this paper
• Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

  2002cited by this paper
• A push–pull approach to maximize vaccine efficacy: Abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L

  2002cited by this paper
• DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses.

  2002cited by this paper
• A push-pull approach to maximize vaccine efficacy : abrogating suppression with an IL-13 inhibitor while augmenting help with GM-CSF and CD40L

  2002cited by this paper
• Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL‐12/GM‐CSF co‐administration

  2002cited by this paper
• Co-immunization of rhesus macaques with plasmid vectors expressing IFN-gamma, GM-CSF, and SIV antigens enhances anti-viral humoral immunity but does not affect viremia after challenge with highly pathogenic virus.

  2002cited by this paper
• Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population.

  2002cited by this paper
• Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection

  2002cited by this paper
• CD4+CD25+ suppressor T cells: more questions than answers

  2002cited by this paper
• Immunostimulatory DNA-Based Vaccines Elicit Multifaceted Immune Responses Against HIV at Systemic and Mucosal Sites1

  2001cited by this paper
• Prime-Boost Immunization with DNA Vaccine: Mucosal Route of Administration Changes the Rules1

  2001cited by this paper
• Impairment of Gag-Specific CD8+ T-Cell Function in Mucosal and Systemic Compartments of Simian Immunodeficiency Virus mac251- and Simian-Human Immunodeficiency Virus KU2-Infected Macaques

  2001cited by this paper
• Enteric microtubule depolymerization in HIV infection: a possible cause of HIV-associated enteropathy.

  2001cited by this paper
• Cytokine Requirements for Induction of Systemic and Mucosal CTL After Nasal Immunization1

  2001cited by this paper
• Activating CTL precursors to reveal CTL function without skewing the repertoire by in vitro expansion

  2001cited by this paper
• Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with sindbis virus-based replicon particles.

  2001cited by this paper
• Mechanisms of cytokine synergy essential for vaccine protection against viral challenge.

  2001cited by this paper
• Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector.

  2001cited by this paper
• Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine

  2001cited by this paper
• Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses

  2001cited by this paper
• Signals delivered through TCR instruct IL-12 receptor (IL-12R) expression: IL-12 and tumor necrosis factor-alpha synergize for IL-12R expression at low antigen dose.

  2001cited by this paper
• Strategies for designing and optimizing new generation vaccines

  2001cited by this paper
• Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques

  2001cited by this paper
• Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.

  2000cited by this paper
• Interplay of Cytokines and Adjuvants in the Regulation of Mucosal and Systemic HIV-Specific CTL

  2000cited by this paper
• Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection

  2000cited by this paper
• Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

  2000cited by this paper
• Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins, Subunits, and Unrelated Adjuvants

  2000cited by this paper
• In Vivo Induction of a High-Avidity, High-Frequency Cytotoxic T-Lymphocyte Response Is Associated with Antiviral Protective Immunity

  2000cited by this paper

• Particulate antigens administrated by intranasal and intravaginal routes in a prime-boost strategy improve HIV-specific TFH generation, high-quality antibodies and long-lasting mucosal immunity.

  2023cites this paper
• Medical Care for Tuberculosis-HIV-Coinfected Patients in Russia with Respect to a Changeable Patients’ Structure

  2022cites this paper
• Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission.

  2019cites this paper
• Mycobacterium tuberculosis–Induced Bronchoalveolar Lavage Gene Expression Signature in Latent Tuberculosis Infection Is Dominated by Pleiotropic Effects of CD4+ T Cell–Dependent IFN-γ Production despite the Presence of Polyfunctional T Cells within the Airways

  2019cites this paper
• Toward DNA-Based T-Cell Mediated Vaccines to Target HIV-1 and Hepatitis C Virus: Approaches to Elicit Localized Immunity for Protection

  2019cites this paper
• Live attenuated Salmonella displaying HIV-1 10E8 epitope on fimbriae: systemic and mucosal immune responses in BALB/c mice by mucosal administration

  2016cites this paper
• Intranasal Vaccination against HIV-1 with Adenoviral Vector-Based Nanocomplex Using Synthetic TLR-4 Agonist Peptide as Adjuvant.

  2016cites this paper
• Intranasal Vaccination Affords Localization and Persistence of Antigen-Specific CD8+ T Lymphocytes in the Female Reproductive Tract

  2016cites this paper
• Mucosal Vaccination for Prevention of HIV Infection and AIDS.

  2016cites this paper
• Peptide–MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development

  2015cites this paper
• Higher Frequency of NK and CD4+ T-Cells in Mucosa and Potent Cytotoxic Response in HIV Controllers

  2015cites this paper
• Lipid-Based Formulations for Oral Drug Delivery: Effects on Drug Absorption and Metabolism.

  2015cites this paper
• Development of oral CTL vaccine using a CTP-integrated Sabin 1 poliovirus-based vector system.

  2015cites this paper
• HIV-1 vaccines

  2014cites this paper
• Development of anti-viral CD8+ T cell memory in the respiratory environment

  2014cites this paper
• Biology of Viruses and Viral Diseases

  2014cites this paper
• Cell Responses in the Respiratory Mucosa Stromal Lymphopoietin on Antiviral CD8 T A Direct and Nonredundant Role for Thymic

  2014cites this paper
• Nonneutralizing Functional Antibodies: a New “Old” Paradigm for HIV Vaccines

  2014cites this paper
• A Direct and Nonredundant Role for Thymic Stromal Lymphopoietin on Antiviral CD8 T Cell Responses in the Respiratory Mucosa

  2014cites this paper
• Memory CD8(+) T cells elicited by HIV-1 lipopeptide vaccines display similar phenotypic profiles but differences in term of magnitude and multifunctionality compared with FLU- or EBV-specific memory T cells in humans.

  2014cites this paper
• Novel approaches in polyepitope T-cell vaccine development against HIV-1

  2014cites this paper
• [Better vaccinations - new approaches for targeted immunomodulation in healthy and immunosuppressed].

  2014cites this paper
• Evolutionarily Conserved Epitopes on Human Immunodeficiency Virus Type 1 (HIV-1) and Feline Immunodeficiency Virus Reverse Transcriptases Detected by HIV-1-Infected Subjects

  2013cites this paper
• A “Prime-Pull” Vaccine Strategy Has a Modest Effect on Local and Systemic Antibody Responses to HIV gp140 in Mice

  2013cites this paper
• Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses

  2013cites this paper
• Interaction between Endogenous Bacterial Flora and Latent HIV Infection

  2013cites this paper
• Mucosal Priming with a Replicating-Vaccinia Virus-Based Vaccine Elicits Protective Immunity to Simian Immunodeficiency Virus Challenge in Rhesus Monkeys

  2013cites this paper
• The interaction between endogenous bacterial flora and the latent HIV ” 5

  2013cites this paper
• From The Department of Microbiology, Tumor and Cell Biology Karolinska Institutet, Stockholm, Sweden STUDIES ON THE HOST IMMUNE RESPONSE DURING PULMONARY TB AND DURING M. TUBERCULOSIS/HIV CO-INFECTION

  2012cites this paper
• Mycobacterium tuberculosis Infection Interferes with HIV Vaccination in Mice

  2012cites this paper
• Improved SIV DNA vaccine can be effectively used as a boost for Ad5 in prime–boost immunization strategy

  2012cites this paper
• Virus-like particles for antigen delivery at mucosal surfaces.

  2012cites this paper
• Studies on the development of a Bacillus endospore-based microparticle vaccine platform

  2011cites this paper
• Anti-HIV therapy: pipeline approaches and future directions.

  2011cites this paper
• Lack of IL‐7 and IL‐15 signaling affects interferon‐γ production by, more than survival of, small intestinal intraepithelial memory CD8+ T cells

  2011cites this paper
• Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.

  2011cites this paper